Abstract
Adolescent and young adult (AYA) patients with cancer may face unique challenges if they and their families wish to participate in clinical oncology trials. Regulatory guidelines and funding requirements put in place to protect patients may actually raise barriers to enrollment in clinical trials. Hospital age guidelines may need to be readdressed to better suit the needs of AYA patients. Finally, the creation of the National Clinical Trials Network will provide new opportunities for pediatric and medical oncologists to collaborate in the care of AYA patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | S119-S122 |
| Journal | Pediatrics |
| Volume | 133 |
| Issue number | SUPPL. 3 |
| DOIs | |
| State | Published - Jun 1 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- AYA oncology
- Regulatory barriers
Fingerprint
Dive into the research topics of 'Regulatory barriers to clinical trial enrollment of adolescent and young adult oncology patients'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS